Risultati della ricerca - Jeremy Pomeroy

Setmelanotide in Bardet‐Biedl Syndrome: A 52‐Week Comparison of Phase 3 Trial Participants With a Matched Registry Cohort di Jesús Argente, Andrea M. Haqq, Jan Luca Schorfheide, Nicolas Touchot, Caroline Huber, Urs Wiedemann, Jeremy Pomeroy

Testo

Clinical burden of hyperphagia, obesity and health outcomes in paediatric individuals with Bardet‐Biedl syndrome: A CRIBBS data analysis di Jeremy Pomeroy, Uzoma Okorie, Jesse G. Richardson, Ariane Faucher, Raluca Ionescu‐Ittu, Francis Vekeman, Caroline Huber, Robert M. Haws

Testo